Merge Healthcare

  
Merge Healthcare's Fusion PACS MX 3.0 integrated with digital mammography 
Merge Healthcare (Booth 4058) is showcasing the capabilities of its Fusion PACS MX 3.0 integrated with digital mammography, its Merge Mammo 7.10 and software solutions from its Cedara division.

The company is demonstrating its Fusion PACS MX 3.0 with integrated digital mammography. The product features Merge Mammo capabilities that can be launched at the PACS workstation, eliminating the need for separate worklists and for sending mammography studies to a different workstation.  Fusion PACS MX 3.0 also is 64-bit compatible, which allows customers to load large breast studies and priors easily. Extended Keyboard shortcuts make the MX workstation look like any previous PACS systems, giving radiologists the option to maintain old interface preferences and lower their learning curve.

Merge Mammo 7.10 is offered as a standalone workstation or integrated into Fusion PACS MX 3.0. As a standalone, this multi-modality, vendor-neutral digital mammography workstation enables imaging centers to use a single workstation to display and read images from different vendors and different acquisition devices, including digital mammography, ultrasound, MR and CT. New features in version 7.10 include support for 12-bit printing and 64-bit architecture, and customer-requested features to speed screening mammography and multi-modality review.

Cedara I-ReadMammo has become the mammography toolset of choice for PACS vendors interested in integrating mammography capabilities. As a multi-modality, vendor-neutral application, Cedara I-ReadMammo was designed to enable radiologists to optimize reading speed and quality of care. Dedicated mammography tools such as skinline detection, optimum view and paired tools accelerate image viewing and make comparisons easier, the company says.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.